Psoriasis Treatment In-Depth Industrial and Market studies - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024
 |
| Psoriasis Treatment |
Albany, New York, Mar 09, 2017
"Psoriasis
Treatment Market - Global Industry Analysis, Size, Share, Growth,
Trends, and Forecast 2017 - 2024"
The Report covers current Industries Trends, Worldwide Analysis,
Global Forecast, Review, Share, Size, Growth, Effect.
Description-
– Global
Psoriasis Treatment Market - Overview
This report on the Psoriasis Treatment market
analyzes the current and future scenario of the global market.
Approval of new biologics, increase in access for the treatment in
developing market, increase in the number of psoriasis patients, are
boosting the growth of the global Psoriasis Treatment market.
Increase in the incidence of Psoriasis and skin disorders, and novel
pipeline drugs are some of the factors expected to drive the growth
of global Psoriasis Treatment market during the forecast period.
The
Psoriasis Treatment market report comprises an elaborate executive
summary, which includes market snapshot that provides information
about various segments. It also provides information and data
analysis of the global market with respect to the segments based on
products, distribution channel, therapy type and geography. A
detailed qualitative analysis of drivers and restraints, and
opportunities has been provided in the market overview section.
Additionally, the section comprises Porter’s
Five Forces Analysis to help understand the competitive landscape in
the market. This section also provides market attractiveness analysis
in terms of geography and market share analysis by key players, thus
presenting a thorough analysis of the overall competitive scenario in
the global Psoriasis Treatment market.
– Global Psoriasis Treatment Market -
Segmentation
In this report, the market segments have been
analyzed based on availability of approved products,
cost-effectiveness, and preference for technological systems by
physicians and patients. The market size and forecast for each of
these segments have been provided for the period from 2014 to 2024,
along with their respective CAGRs for the forecast period from 2017
to 2024, considering 2015 as the base year.
Based on product type, the market has been
segmented into TNF Inhibitors, Vitamin D analogues or its
combination, Interleukin Blockers and Others. Interleukin blockers
segment is likely to be the most attractive segment in the near
future due to its increasing use and its ability to act selectively
by targeting the proteins. The segment is expected to grow at a
highest CAGR rate during forecast period.
Based on Therapy type, the global Psoriasis
Treatment market has been segmented into Topical Therapeutic Drugs,
Systemic Therapeutic Drugs, Combinations of therapies & others.
The market segments have been extensively analyzed based on increase
in demand for the therapies, availability of the drug products, and
cost of therapy and severity of the disease.
Different types of distribution channels are
responsible for making the psoriasis treatment available in the
market. The distribution channels are Hospital pharmacy, Retail
pharmacy and the online sales. Under the distribution channel
segment, hospital pharmacy plays a major role followed by retail
pharmacy and online sales.
Geographically, the global Psoriasis Treatment
market has been categorized into five major regions and the key
countries in the respective region: North America (U.S. and Canada),
Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe),
Asia Pacific (India, Japan, China, Australia & New Zealand, and
Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of
Latin America) and Middle East & Africa (South Africa, Saudi
Arabia, and Rest of Middle East & Africa).
– Companies Mentioned in the Report
The report also profiles major players in the
global Psoriasis Treatment market based on various attributes such as
company overview, financial overview, product portfolio, business
strategies, SWOT analysis, and recent developments. Major players
profiled in this report include Amgen Inc., Eli Lilly and Company,
Novartis AG, Merck & Co., Inc., Johnson & Johnson, Pfizer,
Inc., AstraZeneca, AbbVie Inc., LEO Pharma A/S and Biogen.
The Global Psoriasis Treatment Market has been
segmented as given below:
– Psoriasis Treatment Market, by
Product
- TNF Inhibitors
- Vitamin D Analogues or Combinations
- Interleukin Blockers
- Others
– Psoriasis Treatment Market, by
Therapy
- Topical Therapeutic Drugs
- Systemic Therapeutic Drugs
- Combinations
- Others
– Psoriasis Treatment Market, by
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Sales
- Others
– Psoriasis Treatment Market, by Region
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- India
- China
- Japan
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Comments
Post a Comment